Skip to main content
SpringerLink
Log in

Osteoporose

  • Chapter
Morbus Bechterew

  • 1544 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Acebes C, de la Piedra C, Traba ML, Seibel MJ, Garcia Martin C, Armas J, Herrero-Beaumont G (1999) Biochemical markers of bone remodeling and bone sialoprotein in ankylosing spondylitis. Clin Chim Acta 289(1–2):99–110

    Article  PubMed  Google Scholar 

  • Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM et al (2001) Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids — A randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum 44(1):202–211

    Article  PubMed  Google Scholar 

  • Alaranta H, Luoto S, Konttinen YT (2002) Traumatic spinal cord injury as a complication to ankylosing spondylitis. An extended report. Clin Exp Rheumatol 20(1):66–68

    PubMed  Google Scholar 

  • Altman RD, Latta LL, Keer R, Renfree K, Hornicek FJ, Banovac K (1995) Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats. J Orthop Trauma 9(5):392–400

    PubMed  Google Scholar 

  • American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 44(7):1496–503

    Google Scholar 

  • Aubin JE (1998) Advances in the osteoblast lineage. Biochem Cell Biol 76(6):899–910

    PubMed  Google Scholar 

  • Bagger YB, Tankó LB, Alexandersen P, Christiansen C (2002) Long-term preventive effect of alendronate on osteoporosis: what happened after withdrawal of treatment? Osteoporos Int 13(Suppl 1):S15

    Google Scholar 

  • Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, Rautaharju P, Harper KD (2002) Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 287(7):847–857

    Article  PubMed  Google Scholar 

  • Bessant R, Keat A (2002) How should clinicians manage osteoporosis in ankylosing spondylitis? J Rheumatol 29(7):1511–1519

    PubMed  Google Scholar 

  • Bjarnason NH, Sarkar S, Duong T, Mitlak B, Delmas PD, Christiansen C (2001) Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis. Osteoporos Int 12(11):922–930

    Article  PubMed  Google Scholar 

  • Black D, Thompson D, Quandt S, Palermo L, Ensrud K, Johnell O (2002) Alendronate reduces risk of vertebral fracture in women with BMD T-scores above −2.5: results from the fracture intervention trial (FIT). Osteoporos Int 13(Suppl 3):S32

    Google Scholar 

  • Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348(9041):1535–1541

    PubMed  Google Scholar 

  • Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, Johnell O (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12(7):519–528

    Article  PubMed  Google Scholar 

  • Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S et al (2000) Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial. J Clin Endocrinol Metab 85(11):4118–4124

    Article  PubMed  Google Scholar 

  • Body JJ, Gaich GA, Scheele WH, Kulkarni PM, Miller PD, Peretz A, Dore RK, Correa-Rotter R et al (2002) A randomized double-blind trial to compare the efficacy of teriparatide with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87(10):4528–4535

    PubMed  Google Scholar 

  • Booth SL, Tucker KL, Chen H, Hannan MT, Gagnon DR, Cupples LA, Wilson PW, Ordovas J et al (2000) Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 71(5):1201–1208

    PubMed  Google Scholar 

  • Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K et al (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346(20):1513–1521

    Article  PubMed  Google Scholar 

  • Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H et al (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359(9313):1187–1193

    Article  PubMed  Google Scholar 

  • Bronson WD, Walker SE, Hillman LS, Keisler D, Hoyt T, Allen SH (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 25(5):929–935

    PubMed  Google Scholar 

  • Bruyn GAW, Westra R, Aarts MHM, Zaanen S, Jansen TLTA (2002) Bone density of calcaneus, lumbar spine and hip in ankylosing spondylitis using quantitative ultrasound and dual energy x-ray absorptiometry: role of duration of disease. Osteoporos Int 13(Suppl 1):S138

    Google Scholar 

  • Campagnuolo G, Bolon B, Feige U (2002) Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis. Arthritis Rheum 46(7):1926–1936

    Article  PubMed  Google Scholar 

  • Capaci K, Hepguler S (2002a) Efficacy of alendronate in the treatment osteoporosis in ankylosing spondylitis: one year preliminary results. Osteoporos Int 13(Suppl 1):S43

    Google Scholar 

  • Capaci K, Hepguler S, Eyigor S, Ozturk C (2002b) Calcaneal quantitative ultrasound in ankylosing spondylitis. Osteoporos Int 13(Suppl 1): S48

    Article  Google Scholar 

  • Chapuy MC, Arlot ME, Delmas PD, Meunier PJ (1994) Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. Br Med J 308(6936):1081–1082

    Google Scholar 

  • Chesnut CH, Silverman S, Andriano K, Genant H, Gimona A, Harris S, Kiel D, LeBoff M et al (2000) A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 109(4):267–276

    PubMed  Google Scholar 

  • Chesnut CH 3rd, Bell NH, Clark GS, Drinkwater BL, English SC, Johnson CC Jr, Notelovitz M, Rosen C et al (1997) Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med 102(1):29–37

    Article  PubMed  Google Scholar 

  • Close J, Ellis M, Hooper R, Glucksman E, Jackson S, Swift C (1999) Prevention of falls in the elderly trial (PROFET): a randomised controlled trial. Lancet 353(9147):93–97

    PubMed  Google Scholar 

  • Cooper C, Carbone L, Michet CJ, Atkinson EJ, O’Fallon WM, Melton LJ 3rd (1994) Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 21(10):1877–1882

    PubMed  Google Scholar 

  • Cosman F, Nieves J, Woelfert L, Formica C, Gordon S, Shen V, Lindsay R (2001) Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal. J Bone Miner Res 16(5):925–931

    PubMed  Google Scholar 

  • Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmeno-pausal osteoporosis. Endocr Rev 23(4):570–578

    Article  PubMed  Google Scholar 

  • Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T et al (1999) The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. JAMA 281(23):2189–2197

    PubMed  Google Scholar 

  • Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280(24):2077–82

    Article  PubMed  Google Scholar 

  • Cummings SR, Chapurlat RD (2000) What PROOF proves about calcitonin and clinical trials. Am J Med 109(4):330–331

    Article  PubMed  Google Scholar 

  • Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM (2002) Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112(4):281–289

    Article  PubMed  Google Scholar 

  • Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D et al (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332(12):767–773

    Article  PubMed  Google Scholar 

  • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337(10):670–676

    Article  Google Scholar 

  • De Laet CE, Van Hout BA, Burger H, Weel AE, Hofman A, Pols HA (1998) Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res 13(10):1587–1593

    PubMed  Google Scholar 

  • Devogelaer JP, Maldague B, Malghem J, Nagant de Deuxchaisnes C (1992) Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single-and dual-photon absorptiometry and with quantitative computed tomography. Arthritis Rheum 35(9):1062–1067

    PubMed  Google Scholar 

  • Diamond TH, Winters J, Smith A, De Souza P, Kersley JH, Lynch WJ, Bryant C (2001) The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study. Cancer 92(6):1444–1450

    Article  PubMed  Google Scholar 

  • Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53(2):117–121

    PubMed  Google Scholar 

  • Dos Santos FP, Constantin A, Laroche M, Destombes F, Bernard J, Mazieres B, Cantagrel A (2001) Whole body and regional bone mineral density in ankylosing spondylitis. J Rheumatol 28(3):547–549

    PubMed  Google Scholar 

  • Dunn CJ, Galinet LA, Wu H, Nugent RA, Schlachter ST, Staite ND, Aspar DG, Elliott GA et al (1993) Demonstration of novel antiarthritic and anti-inflammatory effects of diphosphonates. J Pharmacol Exp Ther 266(3):1691–1698

    PubMed  Google Scholar 

  • Eastell R, Cedel SL, Wahner HW, Riggs BL, Melton LJ 3rd (1991) Classification of vertebral fractures. J Bone Miner Res 6(3):207–215

    PubMed  Google Scholar 

  • Eisman JA (1999) Genetics of osteoporosis. Endocr Rev 20(6):788–804

    PubMed  Google Scholar 

  • El Maghraoui A, Borderie D, Cherruau B, Edouard R, Dougados M, Roux C (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26(10):2205–2209

    PubMed  Google Scholar 

  • Engelke K (2002) Quantitative Computertomographie. Journal für Mineralstoffwechsel 9(4):22–31

    Google Scholar 

  • Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282(7):637–645

    PubMed  Google Scholar 

  • Falkenbach A, Herold M (1998) In ankylosing spondylitis serum interleukin-6 correlates with the degree of mobility restriction, but not with short-term changes in the variables for mobility. Rheumatol Int 18(3):103–106

    Article  PubMed  Google Scholar 

  • Falkenbach A, Tripathi R, Sedlmeyer A, Staudinger M, Herold M (2001) Serum 25-hydroxyvitamin D and parathyroid hormone in patients with ankylosing spondylitis before and after a three-week rehabilitation treatment at high altitude during winter and spring. Wien Klin Wochenschr 113(9):328–332

    PubMed  Google Scholar 

  • Felsenberg D (1999) Knochendichtemessung mit Zwei-Spektren-Methoden. Radiologe 39(3):186–193

    Article  PubMed  Google Scholar 

  • Feskanich D, Willett W, Colditz G (2002) Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA 288(18):2300–2306

    Article  PubMed  Google Scholar 

  • Franck H, Keck E (1993) Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis. Ann Rheum Dis 52(5):343–346

    PubMed  Google Scholar 

  • Fratzl P, Schreiber S, Roschger P, Lafage MH, Rodan G, Klaushofer K (1996) Effects of sodium fluoride and alendronate on the bone mineral in minipigs: a small-angle X-ray scattering and backscattered electron imaging study. J Bone Miner Res 11(2):248–253

    PubMed  Google Scholar 

  • Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G et al (1996) Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. J Bone Miner Res 11(10):1531–1538

    PubMed  Google Scholar 

  • Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15(8):1526–1536

    PubMed  Google Scholar 

  • Genant HK, Jergas M, Palermo L, Nevitt M, Sanvalentin R, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res 11(7):984–996

    PubMed  Google Scholar 

  • Geusens P, Vosse D, van der Heijde D, Vanhoof J, van Tubergen A, Raus J, van der Linden S (2001) High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis. J Rheumatol 28(8):1856–1861

    PubMed  Google Scholar 

  • Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, Nanes MS (2000) Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141(11):3956–3964

    Article  PubMed  Google Scholar 

  • Gorman JD, Sack KE, Davis JC (2002) Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 346(18):1349–1356

    Article  PubMed  Google Scholar 

  • Gratacos J, Collado A, Filella X, Sanmarti R, Canete J, Llena J, Molina R, Ballesta A et al (1994) Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 33(10):927–931

    PubMed  Google Scholar 

  • Gratacos J, Collado A, Pons F, Osaba M, Sanmarti R, Roque M, Larrosa M, Munoz-Gomez J (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum 42(11):2319–2324

    Article  PubMed  Google Scholar 

  • Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB (1998) Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Miner Res 13(9):1431–1438

    PubMed  Google Scholar 

  • Gregg EW, Cauley JA, Seeley DG, Ensrud KE, Bauer DC (1998) Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 129(2):81–88

    PubMed  Google Scholar 

  • Haberland M, Schilling AF, Rueger JM, Amling M (2001) Brain and bone: central regulation of bone mass. A new paradigm in skeletal biology. J Bone Joint Surg Am 83(12):1871–1876

    PubMed  Google Scholar 

  • Hanson CA, Shagrin JW, Duncan H (1971) Vertebral osteoporosis in ankylosing spondylitis. Clin Orthop 74:59–64

    PubMed  Google Scholar 

  • Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH, Brown J et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis — A randomized controlled trial. JAMA 282(14):1344–1352

    Article  PubMed  Google Scholar 

  • Hofbauer LC, Heufelder AE (2000) The role of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. J Clin Endocrinol Metab 85(7):2355–2363

    Article  PubMed  Google Scholar 

  • Hunter T, Dubo HI (1983) Spinal fractures complicating ankylosing spondylitis. A long-term followup study. Arthritis Rheum 26(6):751–759

    PubMed  Google Scholar 

  • Igarashi K, Woo JT, Stern PH (2002) Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro. Biochem Pharmacol 63(3):523–532

    Article  PubMed  Google Scholar 

  • Johansson AG, Eriksen EF, Lindh E, Landahl B, Blum WF, Lindahl A, Ljunggren O, Ljunghall S (1997) Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. J Clin Endocrinol Metab 82(9):2795–2798

    Article  PubMed  Google Scholar 

  • Johnell O, De Laet C, Johansson H, Melton LJ, Eisman J, Reeve J, Tenenthouse A, McCloskey EV et al (2002a) Oral corticosteroids increase fracturre risk independently of BMD. Osteoporos Int 13(Suppl 1):S14

    Article  Google Scholar 

  • Johnell O, Oden A, De Laet C, Garnero P, Delmas PD, Kanis JA (2002b) Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int 13(7):523–526

    Article  PubMed  Google Scholar 

  • Juanola X, Mateo L, Nolla JM, Roig-Vilaseca D, Campoy E, Roig-Escofet D (2000) Bone mineral density in women with ankylosing spondylitis. J Rheumatol 27(4):1028–1031

    PubMed  Google Scholar 

  • Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C, Delmas P, Eisman J et al (2002) A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 13(7):527–536

    Article  PubMed  Google Scholar 

  • Kanis JA, Gluer CC (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 11(3):192–202

    Article  PubMed  Google Scholar 

  • Kanis JA, Johnell O, Oden A, De Laet C, Oglesby A, Jonsson B (2002) Intervention thresholds for osteoporosis. Bone 31(1):26–31

    Article  PubMed  Google Scholar 

  • Kanis JA, Johnell O, Oden A, Jonsson B, Dawson A, Dere W (2000a) Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int 11(2):120–127

    PubMed  Google Scholar 

  • Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B (2000b) Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11(8):669–674

    Article  PubMed  Google Scholar 

  • Kannus P, Parkkari J, Niemi S, Pasanen M, Palvanen M, Jarvinen M, Vuori I (2000) Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med 343(21):1506–1513

    PubMed  Google Scholar 

  • Kelley GA, Kelley KS, Tran ZV (2000) Exercise and bone mineral density in men: a meta-analysis. J Appl Physiol 88(5):1730–1736

    PubMed  Google Scholar 

  • Khosla S (2001) Minireview: The OPG/RANKL/RANK system. Endocrinology 142(12):5050–5055

    Article  PubMed  Google Scholar 

  • Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP (2000) Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers. J Clin Endocrinol Metab 85(9):3069–3076

    Article  PubMed  Google Scholar 

  • Lange U, Jung O, Teichmann J, Neeck G (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 12(12):1031–1035

    Article  PubMed  Google Scholar 

  • Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 5(12):507–511

    PubMed  Google Scholar 

  • Lee YSL, Schlotzhauer T, Ott SM, Vanvollenhoven RF, Hunter J, Shapiro J, Marcus R, Mcguire JL (1997) Skeletal status of men with early and late ankylosing spondylitis. Am J Med 103(3):233–241

    Article  PubMed  Google Scholar 

  • Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F (1997) Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350(9077):550–555

    Article  PubMed  Google Scholar 

  • Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320–323

    PubMed  Google Scholar 

  • MacDonald AG, Birkinshaw G, Durham B, Bucknall RC, Fraser WD (1997) Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. Br J Rheumatol 36(1):50–53

    Article  PubMed  Google Scholar 

  • Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, Skeith KJ, Aaron SL et al (2002) A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 46(3):766–773

    Article  PubMed  Google Scholar 

  • Maksymowych WP, Jhangri GS, Leclercq S, Skeith K, Yan A, Russell AS (1998) An open study of pamidronate in the treatment of refractory ankylosing spondylitis. J Rheumatol 25(4):714–717

    PubMed  Google Scholar 

  • Malabanan A, Veronikis IE, Holick MF (1998) Redefining vitamin D insufficiency. Lancet 351(9105):805–806

    Article  Google Scholar 

  • Marhoffer W, Stracke H, Masoud I, Scheja M, Graef V, Bolten W, Federlin K (1995) Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis. Ann Rheum Dis 54(7):556–559

    PubMed  Google Scholar 

  • Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259

    PubMed  Google Scholar 

  • Masud T, Langley S, Wiltshire P, Doyle DV, Spector TD (1993) Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 307(6897):172–173

    PubMed  Google Scholar 

  • May PJ, Raunest J, Herdmann J, Jonas M (2002) Behandlung der Wirbelsäulenfraktur bei ankylosierender Spondylitis. Unfallchirurg 105(2):165–169

    PubMed  Google Scholar 

  • McCloskey EV, Spector TD, Eyres KS, Fern ED, O’Rourke N, Vasikaran S, Kanis JA (1993) The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 3(3):138–147

    Article  PubMed  Google Scholar 

  • McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344(5):333–340

    PubMed  Google Scholar 

  • Meunier PJ, Sebert JL, Reginster JY, Briancon D, Appelboom T, Netter P, Loeb G, Rouillon A et al (1998) Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy. Osteoporos Int 8(1):4–12

    Article  PubMed  Google Scholar 

  • Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468

    PubMed  Google Scholar 

  • Mitra D, Elvins DM, Collins AJ (1999a) Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures. J Rheumatol 26(10):2201–4

    PubMed  Google Scholar 

  • Mitra D, Elvins DM, Collins AJ (1999b) Testosterone and testosterone free index in mild ankylosing spondylitis: relationship with bone mineral density and vertebral fractures. J Rheumatol 26(11):2414–2417

    PubMed  Google Scholar 

  • Mitra D, Elvins DM, Speden DJ, Collins AJ (2000) The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology (Oxford) 39(1):85–89

    Article  PubMed  Google Scholar 

  • Moore KD, Goss K, Anglen JO (1998) Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: a randomised, prospective study. J Bone Joint Surg Br 80(2):259–263

    Article  PubMed  Google Scholar 

  • Mullaji AB, Upadhyay SS, Ho EK (1994) Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases. J Bone Joint Surg Br 76(4):660–665

    PubMed  Google Scholar 

  • Murray GC, Persellin RH (1981) Cervical fracture complicating ankylosing spondylitis: a report of eight cases and review of the literature. Am J Med 70(5):1033–1041

    Article  PubMed  Google Scholar 

  • Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF et al (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434–1441

    PubMed  Google Scholar 

  • NIH Consensus Development Conference on Osteoporosis Prevention, Diagnosis, and Therapy (2000). NIH Consens Statement Online 17(1):1–45

    Google Scholar 

  • O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11(7):1010–1018

    PubMed  Google Scholar 

  • Obermayer-Pietsch BM, Lange U, Tauber G, Frühauf G, Fahrleitner A, Dobnig H, Hermann J, Aglas F et al (2003) Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis. Osteoporos Int 14(12):995–1000

    Article  PubMed  Google Scholar 

  • Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K et al (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343(9):604–610

    PubMed  Google Scholar 

  • Orwoll ES, Scheele WH, Paul S, Adami S, Syversen U, Diez-Perez A, Kaufman JM, Clancy AD et al (2003) The effect of teriparatide [human parathyroid hormone (1–3 4)] therapy on bone density in men with osteoporosis. J Bone Miner Res 18(1):9–17

    PubMed  Google Scholar 

  • Osgood CP, Abbasy M, Mathews T (1975) Multiple spine fractures in ankylosing spondylitis. J Trauma 15(2):163–166

    PubMed  Google Scholar 

  • Pedersen W, Clausen S, Kriegbaum NJ (1987) Spinal lesions in patients with ankylosing spondylitis. Scand J Rheumatol 16(5):381–382

    PubMed  Google Scholar 

  • Pennanen N, Lapinjoki S, Urtti A, Monkkonen J (1995) Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro. Pharm Res 12(6):916–922

    Article  PubMed  Google Scholar 

  • Pfeifer M, Begerow B, Minne HW (2002) The orthosis Spinomed improves posture, lung function, trunk muscle strength, and quality of life in postmenopausal women with spinal osteoporosis: results of a prospective, randomized, controlled, cross-over study. Osteoporos Int 13(Suppl 1):S44

    Article  Google Scholar 

  • Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C (2000) Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15(6):1113–1118

    PubMed  Google Scholar 

  • Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104(10):1363–1374

    PubMed  Google Scholar 

  • Ralston SH (2002) Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 87(6):2460–2466

    Article  PubMed  Google Scholar 

  • Ralston SH, Urquhart GD, Brzeski M, Sturrock RD (1990) Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 300(6724):563–565

    PubMed  Google Scholar 

  • Recker RR, Stakkestad JA, Felsenberg D, Chesnut CH, Christiansen C, Ettinger MP, Nordby A, Weiss SR et al (2000) A new treatment paradigm: quarterly injections of ibandronate reduce the risk of fractures in women with postmenopausal osteoporosis (pmo): results of a 3-year trial. Osteoporos Int 11(14): S209

    Google Scholar 

  • Redlich K, Hayer S, Maier A, Dunstan CR, Tohidast-Akrad M, Lang S, Turk B, Pietschmann P et al (2002) Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 46(3):785–792

    Article  PubMed  Google Scholar 

  • Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11(1):83–91

    PubMed  Google Scholar 

  • Rehman Q, Lang T, Modin G, Lane NE (2002) Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy. Arthritis Rheum 46(5):1292–1297

    Article  PubMed  Google Scholar 

  • Reid DM, Nicoll JJ, Kennedy NS, Smith MA, Tothill P, Nuki G (1986) Bone mass in ankylosing spondylitis. J Rheumatol 13(5):932–935

    PubMed  Google Scholar 

  • Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer J et al (2002) Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346(9):653–661

    Article  PubMed  Google Scholar 

  • Romas E, Sims NA, Hards DK, Lindsay M, Quinn JW, Ryan PF, Dunstan CR, Martin TJ et al (2002) Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol 161(4):1419–1427

    PubMed  Google Scholar 

  • Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333

    PubMed  Google Scholar 

  • Sansoni P, Passeri G, Fagnoni F, Mohagheghpour N, Snelli G, Brianti V, Engleman EG (1995) Inhibition of antigen-presenting cell function by alendronate in vitro. J Bone Miner Res 10(11):1719–1725

    PubMed  Google Scholar 

  • Selby PL, Davies M, Adams JE (2000) Do men and women fracture bones at similar bone densities? Osteoporos Int 11(2):153–157

    Article  PubMed  Google Scholar 

  • Shearer MJ (2000) Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 3(6):433–438

    Article  PubMed  Google Scholar 

  • Shiraki M, Shiraki Y, Aoki C, Miura M (2000) Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15(3):515–521

    PubMed  Google Scholar 

  • Simon AM, Manigrasso MB, O’Connor JP (2002) Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 17(6):963–976

    PubMed  Google Scholar 

  • Sinaki M, Itoi E, Wahner HW, Wollan P, Gelzcer R, Mullan BP, Collins DA, Hodgson SF (2002) Stronger back muscles reduce the incidence of vertebral fractures: a prospective 10 year follow-up of postmenopausal women. Bone 30(6):836–841

    PubMed  Google Scholar 

  • Singh A, Bronson W, Walker SE, Allen SH (1995) Relative value of femoral and lumbar bone mineral density assessments in patients with ankylosing spondylitis. South Med J 88(9):939–943

    PubMed  Google Scholar 

  • Sivri A, Kilinc S, Gokce-Kutsal Y, Ariyurek M (1996) Bone mineral density in ankylosing spondylitis. Clin Rheumatol 15(1):51–54

    PubMed  Google Scholar 

  • Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F, Baulieu EE (2001) Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 86(7):3086–3090

    Article  PubMed  Google Scholar 

  • Speden DJ, Calin AI, Ring FJ, Bhalla AK (2002) Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis. J Rheumatol 29(3):516–521

    PubMed  Google Scholar 

  • Szejnfeld VL, Monier-Faugere MC, Bognar BJ, Ferraz MB, Malluche HH (1997) Systemic osteopenia and mineralization defect in patients with ankylosing spondylitis. J Rheumatol 24(4):683–688

    PubMed  Google Scholar 

  • Tangpricha V, Pearce EN, Chen TC, Holick MF (2002) Vitamin D insufficiency among free-living healthy young adults. Am J Med 112(8):659–662

    Article  PubMed  Google Scholar 

  • Tapia-Serrano R, Jimenez-Balderas FJ, Murrieta S, Bravo-Gatica C, Guerra R, Mintz G (1991) Testicular function in active ankylosing spondylitis. Therapeutic response to human chorionic gonadotrophin. J Rheumatol 18(6):841–848

    PubMed  Google Scholar 

  • Thiebaud D, Burckhardt P, Melchior J, Eckert P, Jacquet AF, Schnyder P, Gobelet C (1994) Two years‘ effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause. Osteoporos Int 4(2):76–83

    Article  PubMed  Google Scholar 

  • Thorngren KG, Liedberg E, Aspelin P (1981) Fractures of the thoracic and lumbar spine in ankylosing spondylitis. Arch Orthop Trauma Surg 98(2):101–107

    Article  PubMed  Google Scholar 

  • Toussirot E, Michel F, Wendling D (2001) Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford) 40(8):882–888

    Article  PubMed  Google Scholar 

  • Toussirot E, Nguyen NU, Dumoulin G, Regnard J, Wendling D (1998) Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis. Br J Rheumatol 37(11):1172–1176

    Article  PubMed  Google Scholar 

  • Toussirot E, Ricard-Blum S, Dumoulin G, Cedoz JP, Wendling D (1999) Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis. Rheumatology (Oxford) 38(1):21–27

    Article  PubMed  Google Scholar 

  • Vallarta-Ast N, Krueger D, Binkley N (2002) Densitometric diagnosis of osteoporosis in men: effect of measurement site and normative database. J Clin Densitom 5(4):383–389

    Article  PubMed  Google Scholar 

  • Van Offel JF, Schuerwegh AJ, Bridts CH, Bracke PG, Stevens WJ, De Clerck LS (2001) Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate. Clin Exp Rheumatol 19(1):13–20

    PubMed  Google Scholar 

  • Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD (1997) Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 82(3):719–724

    Article  PubMed  Google Scholar 

  • Wallace BA, Cumming RG (2000) Systematic review of randomized trials of the effect of exercise on bone mass in pre-and postmenopausal women. Calcif Tissue Int 67(1):10–18

    PubMed  Google Scholar 

  • Wallach S, Cohen S, Reid DM, Hughes RA, Hosking DJ, Laan RF, Doherty SM, Maricic M et al (2000) Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 67(4):277–285

    Article  PubMed  Google Scholar 

  • WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129

    Google Scholar 

  • Will R, Palmer R, Bhalla AK, Ring F, Calin A (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2(8678–8679):1483–1485

    Article  PubMed  Google Scholar 

  • Yu W, Gluer CC, Fuerst T, Grampp S, Li J, Lu Y, Genant HK (1995) Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women. Calcif Tissue Int 57(3):169–174

    Article  PubMed  Google Scholar 

  • Zacher J, Gursche A (2001) Fraktur der versteiften Wirbelsäule bei Spondylitis ankylosans. Z Rheumatol 60(6):513–514

    PubMed  Google Scholar 

Download references

Authors
  1. Gerd Finkenstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sonderkrankenanstalt — Rehabilitationszentrum Bad Ischl-Lindau Pensionsversicherungsanstalt, Bad Ischl, Österreich

    Albrecht Felkenbach

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag/Wien

About this chapter

Cite this chapter

Finkenstedt, G. (2005). Osteoporose. In: Felkenbach, A. (eds) Morbus Bechterew. Springer, Vienna. https://doi.org/10.1007/3-211-26646-1_17

Download citation

  • DOI: https://doi.org/10.1007/3-211-26646-1_17

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-00808-9

  • Online ISBN: 978-3-211-26646-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation